Catalyst Wire Dossier Catalyst Wire Dossier

XIFAXAN

rifaximin · Salix Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for XIFAXAN, covering 2006-05-09 to 2023-10-19. Get the full timeline:

Most recent: FDA Approved: XIFAXAN — Supplemental Application (Salix Pharmaceuticals, Inc.)

See pricing